Work

The L-MIND Trial of the Anti-CD19 Antibody Tafasitamab Combined With Lenalidomide for Lower Risk Relapsed DLBCL

Year: 2020

Type: article

Source: The Hematologist

Authors: Michael D. Jain, Frederick L. Locke

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3088845964

FWCI:

Cites: 9

Cited by:

Related to: 20